Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...

The U.S. Patent and Trademark Office plans to grant the UC Berkeley two patents related to CRISPR gene editing — a significant achievement for the university, which has been in a years-long patent ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in people with transthyretin amyloidosis. One of those tests remains suspended ...

After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs ...